Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2010
06/08/2010US7732576 for identification on human chromosome 10 of a tumor suppressor gene;
06/08/2010US7732575 Proteins bonded to solid supports
06/08/2010US7732417 Methods and compositions for RNA interference using recombinant Dicer and Argonaut
06/08/2010US7732410 applying an antiproliferative agent capable of removing sialic acid residues, such as trans-sialidase, neuraminidase with plant extracts comprising nucleic acid-containing particles from garlic, ginkgo, tomato, orchid, guava, ginseng, ginger, and tobacco; anticholesterol agent
06/08/2010US7732409 EspFU nucleic acids and proteins and uses thereof
06/08/2010US7732402 Mammalian telomerase
06/08/2010US7732377 Methods for producing members of specific binding pairs
06/08/2010US7732207 Method for expression of small antiviral RNA molecules within a cell
06/08/2010US7732201 neural cells comprising a neuroblast and a nestin-positive neural cell; for treating neuronal disorders
06/08/2010US7732197 Recombinant nucleic acid of a nucleotide sequence encoding an autocatalytically cleaving and trans-acting ribozymes linked to a tissue-specific or pathogen-specific promoter; anticancer or antiproliferative agents
06/08/2010US7732193 Expressing preferential nucleotide sequences in cells; obtain cell, transfect, recover packaged retrovirus, infect target cell, monitor gene expression in cell
06/08/2010US7732185 Plasmid having response to dioxins, transgenic cell for measuring dioxins, dioxins sensing method and biosensor using the same
06/08/2010US7732181 Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product
06/08/2010US7732179 Mutants of pyrroloquinoline quinone dependent soluble glucose dehydrogenase
06/08/2010US7732178 Laccase enzymes and their uses
06/08/2010US7732177 Inactive 2',5' Oligo-adenylate synthetase (OAS) for use as viricidal and antitumor therapeutic
06/08/2010US7732169 Method for detecting West Nile virus nucleic acids in the 5′ non-coding/capsid region
06/08/2010US7732162 Anticancer agents; therapy for infections; administering glutaminyl cyclase inhibitor such as 1-(3-(1H-imidazole-1-yl)propyl)-3-(3,4-dimethoxy-phenyl)thiourea hydrochloride; Alzheimer's disease; Down syndrome; controlling fertility; schizophrenia; skin disorders; dementia
06/08/2010US7732161 fermentation method that converts hydroxymethylglutaryl-CoA to L-mevalonic acid and eventually to isoprenoids (farnesol and geranylgeraniol )
06/08/2010US7732159 Using plasminogin activator concentration as indicator of tumor progress and antitumor drug efficacy
06/08/2010US7732155 Using sequence similarity to identify preferential acytransferases; enhancing polyunsaturated fatty acids (PUFA), and oils in cells
06/08/2010US7732151 insulin receptor substrate (IRS) proteins; assay for determining the ability of an enzyme, functional fragment, or functional derivative thereof to modify the phosphorylation status of a biotinylated polypeptide
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7732145 Method and devices for rapid diagnosis of foot-and-mouth disease
06/08/2010US7732144 assessing levels of expression of Thymidylate Synthase (TS) and Excision Repair Cross-Complementing (ERCC1) mRNA obtained from fixed or fixed and paraffin-embedded (FPE) tumor cells
06/08/2010US7732143 characterized by substantial impairments of the genome, either in its structure, deletion or translocation and methods which allow genes to be located and mapped rapidly
06/08/2010US7732142 Sequences diagnostic for shrimp pathogens
06/08/2010US7732141 Methods for evaluating drug-resistance gene expression in the cancer patient
06/08/2010US7732140 Method for direct electrical detection of molecules and molecule-molecule interactions
06/08/2010US7732139 Multiple SNP for diagnosing cardiovascular disease, microarray and kit comprising the same, and method of diagnosing cardiovascular disease using the same
06/08/2010US7732138 use of Allele-Specific-Oligonucleotide (ASO) as a detection assay for human Human Leukocytic Antigens (HLA) classification; rapid, definitive and accurate; genomic analysis; forensics; paternity testing
06/08/2010US7732137 Selecting animals for desired genotypic or potential phenotypic properties
06/08/2010US7732136 Using multicompartment apparatus for cyclic propagation of preferential nucleotide sequences; DNA amplification
06/08/2010US7732135 comprises variants of IL-4 receptor alpha, IL13 and CD14; determining an individual's propensity to a peanut allergy, eczema
06/08/2010US7732134 Methods to predict cholesterol elevation during immunosuppressant therapy
06/08/2010US7732132 hybridoma cell line that produces a monoclonal antibody against the NSs proteins of WSMoV-serogroup tospoviruses
06/08/2010US7732131 Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor
06/08/2010US7732130 Immunoprotective influenza antigen and its use in vaccination
06/08/2010US7732129 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation
06/08/2010US7732128 Apparatus which utilizes atp concentration as a diagnostic indicator of cell viability; high throughput assay and cancer drug screening
06/08/2010US7732127 Dynamic monitoring of cell adhesion and spreading using the RT-CES system
06/08/2010US7731980 Polymorphic membrane proteins (pmp), amino acid and nucleotide sequences, antibodies specific for polymorphic membrane proteins, polypeptides, prophylactic and therapeutic compositions
06/08/2010US7731967 Compositions for inducing immune responses
06/08/2010US7731956 Exhibit altered chondroitin lyase activity or increased resistance to inactivation from stressors including exposure to ultraviolet radiation or heat; administered following a contusion or spinal cord injury to the central nervous system
06/08/2010US7731835 monitoring analyte glucose concentration in a biological fluid by applying a potential to the electrode, comparison with known concentrations of the analyte in medium
06/08/2010US7731828 Method for rapid typification of microorganisms and set of reagents used
06/08/2010CA2422295C A gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene
06/08/2010CA2369010C Method for determining level of folate in a biological sample
06/08/2010CA2368135C Xylo-lna analogues
06/08/2010CA2343010C Card for counting and characterising micro-organisms
06/08/2010CA2322019C Mass spectrometric methods for biomolecular screening
06/08/2010CA2320390C Pna and dna conjugates and methods for preparation thereof
06/08/2010CA2158047C Allergenic protein and peptides from house dust mite and uses therefor
06/08/2010CA2144475C Polyamide-oligonucleotide derivatives, their preparation and use
06/08/2010CA1341606C Activation of nf-kb precursor
06/05/2010CA2645883A1 Selective detection of human rhinovirus
06/03/2010WO2010063011A2 Methods for the treatment of infections and tumors
06/03/2010WO2010062960A2 METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
06/03/2010WO2010062951A2 Animal model for osteoarthritis and intervertebral disc disease
06/03/2010WO2010062914A1 Methods for identifying cancer risk
06/03/2010WO2010062909A1 Broad range pcr-based compositions and methods for the detection and identification of fungal pathogens
06/03/2010WO2010062903A2 Genomic sequencing using modified protein pores and ionic liquids
06/03/2010WO2010062897A1 Methods and compositions to detect clostridium difficile
06/03/2010WO2010062801A1 Nanoparticulate affinity capture for label independent detection system
06/03/2010WO2010062781A2 Methods, kits, and reaction mixtures for high resolution melt genotyping
06/03/2010WO2010062775A2 Methods for detecting modification resistant nucleic acids
06/03/2010WO2010062763A1 Gene expression profiling for predicting the survivability of melanoma subjects
06/03/2010WO2010062738A1 Diagnosis and treatment of congenital heart defects using nell 1
06/03/2010WO2010062706A2 Methods for assessing rna patterns
06/03/2010WO2010062697A2 Membrane-integrated viral dna-packaging motor protein connector biosensor for dna sequencing and other uses
06/03/2010WO2010062683A2 Structure for molecular separations
06/03/2010WO2010062654A2 Device and method for the study of cell and tissue function
06/03/2010WO2010062650A2 Neamine compositions and methods of use thereof
06/03/2010WO2010062556A1 Fast results hybrid capture assay and system
06/03/2010WO2010062546A1 Fast results hybrid capture assay on an automated platform
06/03/2010WO2010062472A1 Methods and systems for measuring microbiological content in aqueous media
06/03/2010WO2010062404A2 N-fmoc nucleosides and phosphoramidites, and oligonucleotide synthesis
06/03/2010WO2010062365A2 A method of protecting against heart failure
06/03/2010WO2010062354A1 Methods for separation, characterization, and/or identification of microorganisms using mass spectrometry
06/03/2010WO2010062352A1 Methods for the isolation and identification of microorganisms
06/03/2010WO2010062350A1 Methods for detection, characterization and/or identification of microorganisms in a sealed container
06/03/2010WO2010062349A1 Methods for separation and characterization of microorganisms using identifier agents
06/03/2010WO2010062344A1 Assay for chlamydia trachomatis by amplification and detection of chlamydia trachomatis pmpa gene
06/03/2010WO2010062317A1 Compositions and methods for detecting food-borne pathogens
06/03/2010WO2010062001A1 Dna chip, kit for detecting or genotyping bacteria causing sexually transmitted diseases, genotyping antibacterial drug resistance and detecting or genotyping method using the same
06/03/2010WO2010061996A1 Diagnostic kit of colon cancer using colon cancer related marker, and diagnostic method therof
06/03/2010WO2010061981A1 Method for measuring cytokeratin-19 mrna
06/03/2010WO2010061922A1 NOVEL MutS PROTEIN AND METHOD OF USING SAME TO DETERMINE MUTATIONS
06/03/2010WO2010061892A1 Novel variable lymphocyte receptor, method for screening for phage capable of binding to target antigen, and method for producing variable lymphocyte receptor for target antigen
06/03/2010WO2010061697A1 Gene sensitive to normal-tension glaucoma disease, and use thereof
06/03/2010WO2010061638A1 Selection of target gene for anti-fungal agent, and method for predicting function of the target gene
06/03/2010WO2010061407A1 Genetic variants useful for risk assessment of thyroid cancer
06/03/2010WO2010061396A1 Methods for detecting an increased susceptibility to cancer
06/03/2010WO2010061393A1 He4 variant nucleotide and amino acid sequences, and methods of use thereof
06/03/2010WO2010061351A1 Oligonucleotides for the detection of aspergillus species
06/03/2010WO2010061347A1 Pcr based diagnostic method for the identification of clinically important candida species
06/03/2010WO2010061246A1 Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment
06/03/2010WO2010061202A1 Assay
06/03/2010WO2010061185A2 Therapeutic target
06/03/2010WO2010061023A1 Colorectal cancer diagnostic method